IDEXX Laboratories, Inc. (LON:0J8P)
Market Cap | 29.33B |
Revenue (ttm) | 3.11B |
Net Income (ttm) | 709.20M |
Shares Out | n/a |
EPS (ttm) | 8.52 |
PE Ratio | 41.35 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 214 |
Average Volume | 311 |
Open | 451.62 |
Previous Close | 448.89 |
Day's Range | 451.55 - 456.54 |
52-Week Range | 373.77 - 583.30 |
Beta | 1.37 |
RSI | 56.74 |
Earnings Date | Feb 3, 2025 |
About IDEXX Laboratories
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnos... [Read more]
Financial Performance
In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.
Financial numbers in USD Financial StatementsNews
IDEXX Laboratories Inc (IDXX) Announces Participation in Upcoming Investor Conferences
IDEXX Laboratories Inc (IDXX) Announces Participation in Upcoming Investor Conferences

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February 27, 9:05 am –...

Options Movement At IDEXX Laboratories: Michael G Erickson Exercises Worth $597K
A substantial insider activity was disclosed on February 12, as Erickson, Executive Vice President at IDEXX Laboratories (NASDAQ: IDXX), reported the exercise of a large sell of company stock options...

Insider Decision: George Fennell Exercises Options At IDEXX Laboratories For $4.28M
In a new SEC filing on February 11, it was revealed that Fennell, Executive Vice President at IDEXX Laboratories (NASDAQ: IDXX), executed a significant exercise of company stock options. What Happene...

M. Anne Szostak Implements A Sell Strategy: Offloads $1.40M In IDEXX Laboratories Stock
A substantial insider sell was reported on February 10, by M. Anne Szostak , Director at IDEXX Laboratories (NASDAQ: IDXX), based on the recent SEC filing. What Happened: Szostak's recent move involv...
IDEXX Laboratories And Its Real Value
Idexx Laboratories (IDXX) Stock Surge: Key Drivers
Idexx Laboratories (IDXX) Stock Surge: Key Drivers

Why Idexx Labs Stock Rocketed Higher This Week

IDEXX Laboratories: I See Pet Healthcare As An Interesting Market For The Future
IDEXX Laboratories is poised for growth in the pet healthcare market. Check out why I see a 50% upside in IDXX stock by FY27.
IDEXX Laboratories Inc (IDXX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
IDEXX Laboratories Inc (IDXX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations Propel Performance
Q4 2024 IDEXX Laboratories Inc Earnings Call Transcript
Q4 2024 IDEXX Laboratories Inc Earnings Call Transcript

Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today's Top S&P 500 Performers.
Idexx Laboratories, AbbVie, and Molina Healthcare trade higher on a down day for Wall Street.
IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ETCompany ParticipantsBrian McKeon - Chief Financial...

IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices
IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price increases.

IDEXX stock jumps 12% as Q4 report, outlook top Street estimates
IDEXX (IDXX) stock jumped 12% in early trading Monday after the pet healthcare company issued a Q4 earnings report and 2025 forecast that topped Street expectations. Read more here.
Idexx Laboratories Barks Up A Beat, And Shares Jump To A Four-Month High
Idexx Laboratories handily beat Wall Street's fourth-quarter expectations Monday, and Idexx stock gapped up to a four-month high.

Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday?
IDEXX Laboratories Inc (NASDAQ: IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40 . The pet healthcare company reported sales of $954.3 millio...

Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday?
IDEXX Laboratories Inc IDXX reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40.

Earnings Summary: Highlights of IDEXX’s Q4 2024 report
Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and net income for the fourth quarter of 2024. Fourth-quarter revenues increased 6% annually to $954.3...

Idexx: Q4 EPS, Revenue Beat Forecast
Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.

Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits
IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to t...
IDEXX Laboratories Exceeds Q4 Estimates with $2.62 EPS and $954 Million Revenue
IDEXX Laboratories Exceeds Q4 Estimates with $2.62 EPS and $954 Million Revenue
IDEXX Laboratories GAAP EPS of $2.62 beats by $0.22, revenue of $954M beats by $17.32M
IDEXX Laboratories beats Q4 expectations with earnings and revenue growth, providing a positive outlook for 2025.

IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results. “IDEXX had a solid finis...

Earnings Scheduled For February 3, 2025
Companies Reporting Before The Bell • Tyson Foods (NYSE: TSN) is projected to report quarterly earnings at $0.88 per share on revenue of $13.46 billion. • Saia (NASDAQ: SAIA) is projected to report ...